Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma
about
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomesA decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancerDefining the role of laminin-332 in carcinoma.Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer.Laminin 332 expression in breast carcinomaOverexpression of β3 Chains of Laminin-332 is Associated With Clinicopathologic Features and Decreased Survival in Patients With Pancreatic Adenocarcinoma.Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells.Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer.Expression of the gamma 2 chain of laminin-332 in eutopic and ectopic endometrium of patients with endometriosis.TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma.The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinomaTargeting the tumor stroma in hepatocellular carcinoma.RNA interference targeting human integrin α6 suppresses the metastasis potential of hepatocellular carcinoma cells.Serum monomeric laminin-γ2 as a novel biomarker for hepatocellular carcinoma.Transforming growth factor β1 promotes migration and invasion in HepG2 cells: Epithelial‑to‑mesenchymal transition via JAK/STAT3 signaling.Recent Advances in Understanding Cholangiocarcinoma.
P2860
Q33570732-1ED75D7B-BC72-487C-B79A-60174E5BEF71Q33849094-EC58B770-53B2-46CF-A37F-284867A39494Q33875126-B1972C81-2A12-436F-9694-C51EE308E8DBQ34756075-EEE8C66A-EFB6-46DD-BF70-E734CB3AE032Q35825928-F461EC06-1C0A-4390-91C8-00F2A731D90DQ35933824-5037C91F-FCCF-4099-83EF-F2A923CB8570Q36695154-3AD1CA9D-49BA-4D5D-8D75-8CBEA569E1EFQ37316815-F996D6F8-133C-4DBA-A142-4272DFBF485BQ37361635-6870D3B4-2941-4BC3-8910-17BA7C536E05Q37705967-E515AA0A-9448-4427-8733-90F1B844E971Q37800217-9DBF61E9-BC89-4014-A1AE-90E93E1DFA90Q38207013-22409471-C20E-45A2-87A2-C0FDB41E03BEQ38366586-EF3003BF-16B7-4672-B741-A7388B5EDD9CQ39049068-A7B7DFAB-89B1-4B75-827D-3755A50AEEC2Q40960457-FB48E967-3314-40BA-AF91-EA6007470FEBQ47120426-BD98638D-BAA7-4241-B68E-B01E152DCFBCQ47165549-02E1D959-9E3F-4755-95C2-DF84AF35A468
P2860
Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma
description
im September 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 September 2003
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2003
@uk
name
Laminin-5 chains are expressed ...... tatic hepatocellular carcinoma
@en
Laminin-5 chains are expressed ...... tatic hepatocellular carcinoma
@nl
type
label
Laminin-5 chains are expressed ...... tatic hepatocellular carcinoma
@en
Laminin-5 chains are expressed ...... tatic hepatocellular carcinoma
@nl
prefLabel
Laminin-5 chains are expressed ...... tatic hepatocellular carcinoma
@en
Laminin-5 chains are expressed ...... tatic hepatocellular carcinoma
@nl
P2093
P1476
Laminin-5 chains are expressed ...... tatic hepatocellular carcinoma
@en
P2093
Emilia Fransvea
Felice Marinosci
Gianluigi Giannelli
Salvatore Antonaci
P304
P407
P433
P577
2003-09-01T00:00:00Z